These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12208432)

  • 1. Lipoprotein changes during acute coronary syndromes.
    Batalla A; Hevia S; Sieres M; Raviña T
    Am J Cardiol; 2002 Sep; 90(5):572. PubMed ID: 12208432
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study.
    Muntner P; Lee F; Astor BC
    Am J Med Sci; 2011 Mar; 341(3):173-80. PubMed ID: 21042169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation between lipoprotein cholesterol and hypertension and coronary heart disease].
    Li BS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1985 Sep; 13(4):273-4. PubMed ID: 3836886
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of 2 electrophoretic procedures for quantifying lipoprotein cholesterol].
    Kessler B; Aufenanger J; Kattermann R
    Klin Wochenschr; 1990; 68 Suppl 22():110-1. PubMed ID: 2087065
    [No Abstract]   [Full Text] [Related]  

  • 5. LDL-cholesterol and HDL-cholesterol in ischaemic heart disease.
    Atukorala TM; Gunarathna PH; Ekanayake RA; Wijayawardhana UD
    Ceylon Med J; 1986 Mar; 31(1):9-14. PubMed ID: 3802308
    [No Abstract]   [Full Text] [Related]  

  • 6. High density lipoprotein and coronary heart disease.
    Betteridge DJ
    BMJ; 1989 Apr; 298(6679):974-5. PubMed ID: 2499385
    [No Abstract]   [Full Text] [Related]  

  • 7. Joint effects of serum triglycerides and LDL and HDL cholesterol.
    Avins AL; Hulley SB
    Circulation; 1993 Jan; 87(1):300-1. PubMed ID: 8419022
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipoprotein and apoprotein A1 levels in diabetics and coronary heart disease patients and controls.
    Pan XR; Hu SX; Gang Y; Jin L; Li XG; Li J; Yan Q; Chen TS
    Chin Med J (Engl); 1987 Mar; 100(3):204-7. PubMed ID: 3113842
    [No Abstract]   [Full Text] [Related]  

  • 9. Coronary risk factors.
    Pearson TA
    Med Sect Proc; 1986; ():33-46. PubMed ID: 3601936
    [No Abstract]   [Full Text] [Related]  

  • 10. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL-cholesterol as a determinant of coronary heart disease.
    Hunninghake D
    Clin Ther; 1990; 12(5):370-5; discussion 369. PubMed ID: 2268861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in triglyceride, HDL-C, and non-HDL-C levels in patients with acute coronary syndrome.
    Koncsos P; Fülöp P; Juhász I; Bíró K; Márk L; Simonyi G; Paragh G
    Wien Klin Wochenschr; 2016 Dec; 128(23-24):858-863. PubMed ID: 27380508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
    Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations.
    Sacks FM;
    Am J Cardiol; 2002 Jul; 90(2):139-43. PubMed ID: 12106843
    [No Abstract]   [Full Text] [Related]  

  • 16. Analyzing of high-density lipoprotein subfractions and low-density lipoprotein subfractions in human serum with anion-exchange chromatography.
    Hirowatari Y; Tsunoda Y; Ogura Y; Homma Y
    Atherosclerosis; 2009 Jun; 204(2):e52-7. PubMed ID: 19091316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct testing for low-density lipoprotein cholesterol.
    Cohen JD
    Am J Cardiol; 1995 Apr; 75(12):831-2. PubMed ID: 7717291
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation of serum lipoproteins to the severity of angiographically defined coronary artery disease.
    Wasir HS; Narula J; Mohan JC; Srivastava LN; Vasisht S; Bhatia ML
    Indian Heart J; 1986; 38(6):462-6. PubMed ID: 3447947
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonoptimal high-density lipoprotein cholesterol levels are highly prevalent in patients presenting with acute coronary syndromes and well-controlled low-density lipoprotein cholesterol levels.
    Felix-Getzik EM; Kuvin JT; Karas RH
    J Clin Lipidol; 2010; 4(4):265-71. PubMed ID: 21122659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is a low fat diet enough to achieve serum cholesterol goals?
    Eichholzer M; Gutzwiller F
    Eur Heart J; 1999 Jul; 20(14):991-4. PubMed ID: 10381849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.